Clinician's Roundtable

Host: Jay Fishman, MD With a global shortage of human organs, xenotransplantation offers a potential new way to save lives. But what are the immunologic barriers? Tune in as Dr. Jay Fishman, Director of Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital, recaps his session from the 2023 IDWeek.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Allison Andreno Norful, PhD, MPhil, MSN, BSN, ANP-BC Emergency departments are demanding, causing ER nurses to experience high levels of work-related stress, and they're at a higher risk of burnout now more than ever before. But what are the causes and factors specific to emergency nurses that can lead to burnout, and why are these nurses leaving the...

Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD The discovery of the IL-23 pathway has revolutionized the treatment of psoriasis. Learn more about the current state of IL-23 inhibition in psoriasis management with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale,...

Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD Our understanding of TYK2’s role in the pathophysiology of psoriasis has recently evolved, leading to new treatment options like deucravacitinib. Deucravacitinib is the first approved TYK2 inhibitor approved for moderate to severe plaque psoriasis. Learn more about this treatment option and the role of TYK2 with Dr. Raj Chovatiya and Dr. Geor...

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Valeria Cantos Lucio, MD HIV diagnoses in the United States have declined two-thirds since the start of the pandemic in the 1980s. However, the Latino community are still facing high risk of infections. To learn more on providing better access to care for these patients, join Dr. Mary Katherine Cheeley as she speaks with Dr. Valeria Cant...

Guest: Terry M. Foster, MSN, RN, CEN, CPEN, CCRN, TCRN, FAEN Attendees can expect a wide range of education sessions, keynote presentations, networking events, and hands-on learning experiences from this year’s Emergency Nurses Association (ENA) annual meeting. Hear from ENA President, Terry Foster, Critical-Care Clinical Nurse Specialist in the Emergency Departments at St. Elizabeth Healthcare, a...

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Generalized pustular psoriasis is a rare inflammatory skin disease that can be life-threatening if left untreated, and treatment typically involves the use of therapies approved for plaque psoriasis. However, that could all be changing thanks to the recent understanding of IL-36’s role in generalized pustular psoriasis and the devel...

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Roflumilast and tapinarof are two of the new topical nonsteroidal therapies for plaque psoriasis that have several advantages over the traditional topical steroids. Learn more about how emerging topical nonsteroidals could impact your patients with plaque psoriasis with Dr. Raj Chovatiya and Dr. Jason Hawkes, a medical dermatologist...

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Dylan Baker, MD Georgia has the highest rate of new HIV diagnoses out of any state in the country, and so it’s imperative that we make this medication more accessible now in order to save future generations from living with HIV. To dive further into the benefits and challenges of this program, Dr. Mary Katherine Cheeley is joined by Dr....

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD Research has shown that those living with HIV are more likely to be malnourished and experience nutrient deficiencies that play an essential role in their immunity. In the early days of HIV, a typical recommendation was to increase a patient’s calorie count. To discuss how the focus on nutrition has changed now that this patie...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD For most patients living with HIV, antiretroviral therapy is extremely effective. However, HIV mutates with frequency, allowing it to become resistant to antiviral medication. To discuss how we can effectively treat these patients, Dr. Charles Turck is joined by Dr. Sorana Segal-Maurer, Director of Infectious Diseases at New Y...

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Sarah Bauerle Bass, PhD, MPH, FSBM Although the rate of new HIV diagnoses in the United States is steadily declining, people in prisons are still disproportionately living with the virus, which is why researchers at Temple University are now developing an app aimed at improving HIV prevention and substance use treatment access for incarc...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kamel Khalili, PhD Scientists at Temple University’s Lewis Katz School of Medicine have identified a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality. Find out how this recent discovery could get us one step closer to a cure for HIV with Dr. Charles Turck and Dr. Kamel Khalili, the Laura H. Ca...

Host: Michael Greenberg, MD Guest: William E. Hauter, MD Illinois lawmakers are taking steps to end intrusive mental health questionnaires for physician licensures. To learn more about Illinois House Bill 3109 and how you can get involved, join Dr. Michael Greenberg as he sits down with Dr. Bill Hauter, Illinois State Representative and Anesthesiologist.

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered associations between socioeconomic factors and visit adherence among patients with glaucoma. Can clinicians use this data to improve visit adherence? Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California-...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Gates B. Colbert, MD When managing a rare disease like IgA nephropathy (IgAN), it’s essential to keep each individual patient at the center of it all, and this type of approach starts at the diagnostic stage. Joining Dr. Charles Turck to share strategies for providing patient-centered care throughout every step of the journey is Dr. Gates Colbert, As...

Host: Frank Cortazar, MD Have you ever heard or thought that IgA nephropathy (IgAN) is only a short-term disease? Or that it’s benign? These are just some of the many common misconceptions surrounding IgAN, which is why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to help debunk these and other prevalent myths.

Host: Frank Cortazar, MD There are several challenges associated with the management of glomerular diseases like IgA nephropathy and C3 glomerulopathy. But in order to overcome those challenges, we must first have a firm understanding of them. That’s why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to break down those common challenges so we can work to...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Carl P. Walther, MD The alternative complement pathway and the lectin pathway are the two pathways that are important in IgA nephropathy (IgAN). So how does the dysregulation of these two pathways impact disease progression, and how might this knowledge help us optimize our approach to treating patients with IgAN? Joining Dr. Charles Turck to answer...

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered how socioeconomic factors such as lower income and education levels were associated with lower odds of seeing an eye doctor. Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California-San Diego, to explore how...

Host: John Russell, MD Guest: Stanton Miller, MD, MPH, FACS Patients who live in an environment impacted by gun violence may face lifelong challenges. But addressing gun violence from a public health standpoint may help clinicians manage the biological, behavioral, and social aspects of this disease. Dr. John Russell is joined by Dr. Stan Miller from the Jefferson Center for Injury Research &...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Clark, MD Emerging treatment options have helped patients with HIV live longer, but the aging population faces its own unique challenges. To explore how we can combat these challenges—including the ongoing stigma around HIV—Dr. Charles Turck is joined by Dr. Andrew Clark, who is the Global Medical Lead at ViiV Healthcare.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: W. Frank Peacock, MD For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP Physicians and advanced practice registered nurses (APRNs) may practice differently but they can still get their patient to the same outcome. So where do the conflicts arise? Join Dr. Peter Buch as he walks us through this with Dr. Wendy Wright, nurse practitioner and founder of Wright & Associat...

Host: Mario R. Nacinovich, Jr., MSc Guest: Walter Koroshetz, MD Amyotrophic lateral sclerosis (ALS) is a rare neurogenerative disease, and organizations including the FDA and NIH are working to accelerate potential therapies. What’s on the horizon for the treatment landscape? Mario Nacinovich joins Dr. Walter Koroshetz, who is the Director of the National Institute of Neurological Disorders and St...